Advanced search
Publication Cover
Expert Review of Vaccines Volume 11, 2012 - Issue 8
Submit an article Journal homepage
375
Views
13
CrossRef citations to date
0
Altmetric
Review

Pediatric influenza vaccination: understanding the T-cell response

Rogier Bodewes Department of Virology, Erasmus MC, Rotterdam, The Netherlands; Department of Virology, Erasmus MC, Rotterdam, The Netherlands
,
Pieter LA Fraaij Department of Virology, Erasmus MC, Rotterdam, The Netherlands; Intensive Care and Department of Pediatric Surgery, Erasmus MC Sophia Children’s Hospital, Rotterdam, The Netherlands; Department of Virology, Erasmus MC, Rotterdam, The Netherlands; Intensive Care and Department of Pediatric Surgery, Erasmus MC Sophia Children’s Hospital, Rotterdam, The Netherlands
,
Albert DME Osterhaus Department of Virology, Erasmus MC, Rotterdam, The Netherlands; ViroClinics Biosciences, Rotterdam, The Netherlands; Department of Virology, Erasmus MC, Rotterdam, The Netherlands; ViroClinics Biosciences, Rotterdam, The Netherlands
&
Guus F Rimmelzwaan Department of Virology, Erasmus MC, Rotterdam, The Netherlands; ViroClinics Biosciences, Rotterdam, The Netherlands; ViroClinics Biosciences, Rotterdam, The Netherlands. [email protected]
Pages 963-971 | Published online: 09 Jan 2014

References

  • Fraaij PL, Bodewes R, Osterhaus AD, Rimmelzwaan GF. The ins and outs of universal childhood influenza vaccination. Future Microbiol. 6(10), 1171–1184 (2011).
  • Fraaij PL, Heikkinen T. Seasonal influenza: the burden of disease in children. Vaccine 29(43), 7524–7528 (2011).
  • Garten RJ, Davis CT, Russell CA et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325(5937), 197–201 (2009).
  • Dawood FS, Jain S, Finelli L et al.; Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 360(25), 2605–2615 (2009).
  • de Jong JC, Claas EC, Osterhaus AD, Webster RG, Lim WL. A pandemic warning? Nature 389(6651), 554 (1997).
  • Wang TT, Parides MK, Palese P. Seroevidence for H5N1 influenza infections in humans: meta-analysis. Science 335(6075), 1463 (2012).
  • Ungchusak K, Auewarakul P, Dowell SF et al. Probable person-to-person transmission of avian influenza A (H5N1). N. Engl. J. Med. 352(4), 333–340 (2005).
  • Wang H, Feng Z, Shu Y et al. Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet 371(9622), 1427–1434 (2008).
  • Kreijtz JH, de Mutsert G, van Baalen CA, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J. Virol. 82(11), 5161–5166 (2008).
  • Jameson J, Cruz J, Ennis FA. Human cytotoxic T-lymphocyte repertoire to influenza A viruses. J. Virol. 72(11), 8682–8689 (1998).
  • Jameson J, Cruz J, Terajima M, Ennis FA. Human CD8+ and CD4+ T-lymphocyte memory to influenza A viruses of swine and avian species. J. Immunol. 162(12), 7578–7583 (1999).
  • Brown DM, Lee S, Garcia-Hernandez Mde L, Swain SL. Multifunctional CD4 cells expressing γ interferon and perforin mediate protection against lethal influenza virus infection. J. Virol. 86(12), 6792–6803 (2012).
  • Zhou X, McElhaney JE. Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans. Vaccine 29(11), 2169–2177 (2011).
  • Brown DM, Román E, Swain SL. CD4 T-cell responses to influenza infection. Semin. Immunol. 16(3), 171–177 (2004).
  • Greenbaum JA, Kotturi MF, Kim Y et al. Preexisting immunity against swine-origin H1N1 influenza viruses in the general human population. Proc. Natl Acad. Sci. USA 106(48), 20365–20370 (2009).
  • Kreijtz JH, Fouchier RA, Rimmelzwaan GF. Immune responses to influenza virus infection. Virus Res. 162(1–2), 19–30 (2011).
  • He XS, Draghi M, Mahmood K et al. T-cell-dependent production of IFN-γ by NK cells in response to influenza A virus. J. Clin. Invest. 114(12), 1812–1819 (2004).
  • He XS, Holmes TH, Sasaki S et al. Baseline levels of influenza-specific CD4 memory T-cells affect T-cell responses to influenza vaccines. PLoS ONE 3(7), e2574 (2008).
  • GeurtsvanKessel CH, Lambrecht BN. Division of labor between dendritic cell subsets of the lung. Mucosal Immunol. 1(6), 442–450 (2008).
  • Grebe KM, Yewdell JW, Bennink JR. Heterosubtypic immunity to influenza A virus: where do we stand? Microbes Infect. 10(9), 1024–1029 (2008).
  • Epstein SL. Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J. Infect. Dis. 193(1), 49–53 (2006).
  • McCaw JM, McVernon J, McBryde ES, Mathews JD. Influenza: accounting for prior immunity. Science 325(5944), 1071; author reply 1072–1071; author reply 1073 (2009).
  • Cowling BJ, Ng S, Ma ES et al. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin. Infect. Dis. 51(12), 1370–1379 (2010).
  • McMichael AJ, Gotch FM, Noble GR, Beare PA. Cytotoxic T-cell immunity to influenza. N. Engl. J. Med. 309(1), 13–17 (1983).
  • Wilkinson TM, Li CK, Chui CS et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat. Med. 18(2), 274–280 (2012).
  • Zaghouani H, Hoeman CM, Adkins B. Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol. 30(12), 585–591 (2009).
  • PrabhuDas M, Adkins B, Gans H et al. Challenges in infant immunity: implications for responses to infection and vaccines. Nat. Immunol. 12(3), 189–194 (2011).
  • Wood N, Siegrist CA. Neonatal immunization: where do we stand? Curr. Opin. Infect. Dis. 24(3), 190–195 (2011).
  • Hodgins DC, Shewen PE. Vaccination of neonates: problem and issues. Vaccine 30(9), 1541–1559 (2012).
  • Tregoning JS, Schwarze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin. Microbiol. Rev. 23(1), 74–98 (2010).
  • Vekemans J, Ota MO, Wang EC et al. T-cell responses to vaccines in infants: defective IFN-γ production after oral polio vaccination. Clin. Exp. Immunol. 127(3), 495–498 (2002).
  • Ota MO, Vekemans J, Schlegel-Haueter SE et al. Hepatitis B immunisation induces higher antibody and memory Th2 responses in newborns than in adults. Vaccine 22(3–4), 511–519 (2004).
  • Marchant A, Goetghebuer T, Ota MO et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette–Guérin vaccination. J. Immunol. 163(4), 2249–2255 (1999).
  • Hussey GD, Watkins ML, Goddard EA et al. Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies. Immunology 105(3), 314–324 (2002).
  • Rowe J, Macaubas C, Monger T et al. Heterogeneity in diphtheria-tetanus-acellular pertussis vaccine-specific cellular immunity during infancy: relationship to variations in the kinetics of postnatal maturation of systemic Th1 function. J. Infect. Dis. 184(1), 80–88 (2001).
  • Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 353(9148), 196–200 (1999).
  • Yabuhara A, Macaubas C, Prescott SL et al. TH2-polarized immunological memory to inhalant allergens in atopics is established during infancy and early childhood. Clin. Exp. Allergy 27(11), 1261–1269 (1997).
  • Lee HH, Hoeman CM, Hardaway JC et al. Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity. J. Exp. Med. 205(10), 2269–2280 (2008).
  • Philbin VJ, Levy O. Developmental biology of the innate immune response: implications for neonatal and infant vaccine development. Pediatr. Res. 65(5 Pt 2), 98R–105R (2009).
  • Fernandez MA, Puttur FK, Wang YM, Howden W, Alexander SI, Jones CA. T regulatory cells contribute to the attenuated primary CD8+ and CD4+ T-cell responses to herpes simplex virus type 2 in neonatal mice. J. Immunol. 180(3), 1556–1564 (2008).
  • Duijts L, Bakker-Jonges LE, Labout JA et al. Fetal growth influences lymphocyte subset counts at birth: the Generation R Study. Neonatology 95(2), 149–156 (2009).
  • Hicks MJ, Jones JF, Minnich LL, Weigle KA, Thies AC, Layton JM. Age-related changes in T- and B-lymphocyte subpopulations in the peripheral blood. Arch. Pathol. Lab. Med. 107(10), 518–523 (1983).
  • Comans-Bitter WM, de Groot R, van den Beemd R et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J. Pediatr. 130(3), 388–393 (1997).
  • Tsegaye A, Wolday D, Otto S et al. Immunophenotyping of blood lymphocytes at birth, during childhood, and during adulthood in HIV-1-uninfected Ethiopians. Clin. Immunol. 109(3), 338–346 (2003).
  • Haines CJ, Giffon TD, Lu LS et al. Human CD4+ T cell recent thymic emigrants are identified by protein tyrosine kinase 7 and have reduced immune function. J. Exp. Med. 206(2), 275–285 (2009).
  • Heikkinen T, Heinonen S. Effectiveness and safety of influenza vaccination in children: European perspective. Vaccine 29(43), 7529–7534 (2011).
  • Bodewes R, de Mutsert G, van der Klis FR et al. Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands. Clin. Vaccine Immunol. 18(3), 469–476 (2011).
  • Sauerbrei A, Schmidt-Ott R, Hoyer H, Wutzler P. Seroprevalence of influenza A and B in German infants and adolescents. Med. Microbiol. Immunol. 198(2), 93–101 (2009).
  • Bodewes R, Kreijtz JH, Hillaire ML et al. Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice. J. Gen. Virol. 91(Pt 7), 1743–1753 (2010).
  • Webster RG, Askonas BA. Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur. J. Immunol. 10(5), 396–401 (1980).
  • Lau YF, Wright AR, Subbarao K. The contribution of systemic and pulmonary immune effectors to vaccine-induced protection from H5N1 influenza virus infection. J. Virol. 86(9), 5089–5098 (2012).
  • Lee KH, Seo SU, Song JM, Lee CM, Kim HA, Seong BL. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus. Vaccine 24(11), 1966–1974 (2006).
  • Chen GL, Lau YF, Lamirande EW, McCall AW, Subbarao K. Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine. Proc. Natl Acad. Sci. USA 108(3), 1140–1145 (2011).
  • Hillaire ML, van Trierum SE, Kreijtz JH et al. Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells. J. Gen. Virol. 92(Pt 10), 2339–2349 (2011).
  • Hillaire ML, Osterhaus AD, Rimmelzwaan GF. Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines. J. Biomed. Biotechnol. 2011, 939860 (2011).
  • Wang TT, Tan GS, Hai R et al. Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc. Natl Acad. Sci. USA 107(44), 18979–18984 (2010).
  • Jegerlehner A, Schmitz N, Storni T, Bachmann MF. Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J. Immunol. 172(9), 5598–5605 (2004).
  • Carragher DM, Kaminski DA, Moquin A, Hartson L, Randall TD. A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus. J. Immunol. 181(6), 4168–4176 (2008).
  • Epstein SL, Lo CY, Misplon JA et al. Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T-cell-depleted, β2-microglobulin-deficient, and J chain-deficient mice. J. Immunol. 158(3), 1222–1230 (1997).
  • Benton KA, Misplon JA, Lo CY, Brutkiewicz RR, Prasad SA, Epstein SL. Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or γδ T cells. J. Immunol. 166(12), 7437–7445 (2001).
  • He XS, Holmes TH, Zhang C et al. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J. Virol. 80(23), 11756–11766 (2006).
  • Hoft DF, Babusis E, Worku S et al. Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J. Infect. Dis. 204(6), 845–853 (2011).
  • Zeman AM, Holmes TH, Stamatis S et al. Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine. Pediatr. Infect. Dis. J. 26(2), 107–115 (2007).
  • Subbramanian RA, Basha S, Shata MT, Brady RC, Bernstein DI. Pandemic and seasonal H1N1 influenza hemagglutinin-specific T-cell responses elicited by seasonal influenza vaccination. Vaccine 28(52), 8258–8267 (2010).
  • Bodewes R, Fraaij PL, Geelhoed-Mieras MM et al. Annual vaccination against influenza virus hampers development of virus-specific CD8+ T-cell immunity in children. J. Virol. 85(22), 11995–12000 (2011).
  • He XS, Holmes TH, Mahmood K et al. Phenotypic changes in influenza-specific CD8+ T cells after immunization of children and adults with influenza vaccines. J. Infect. Dis. 197(6), 803–811 (2008).
  • Bodewes R, Kreijtz JH, Rimmelzwaan GF. Yearly influenza vaccinations: a double-edged sword? Lancet Infect. Dis. 9(12), 784–788 (2009).
  • Bodewes R, Kreijtz JH, Baas C et al. Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus. PLoS ONE 4(5), e5538 (2009).
  • Zaman K, Roy E, Arifeen SE et al. Effectiveness of maternal influenza immunization in mothers and infants. N. Engl. J. Med. 359(15), 1555–1564 (2008).
  • Steinhoff MC, Omer SB, Roy E et al. Influenza immunization in pregnancy – antibody responses in mothers and infants. N. Engl. J. Med. 362(17), 1644–1646 (2010).
  • Berthoud TK, Hamill M, Lillie PJ et al. Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. Clin. Infect. Dis. 52(1), 1–7 (2011).
  • Rimmelzwaan GF, Nieuwkoop N, Brandenburg A et al. A randomized, double blind study in young healthy adults comparing cell-mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines. Vaccine 19(9-10), 1180–1187 (2000).
  • Shanks GD, Brundage JF. Pathogenic responses among young adults during the 1918 influenza pandemic. Emerging Infect. Dis. 18(2), 201–207 (2012).
  • Heinen PP, Rijsewijk FA, de Boer-Luijtze EA, Bianchi AT. Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus. J. Gen. Virol. 83(Pt 8), 1851–1859 (2002).
  • Gauger PC, Vincent AL, Loving CL et al. Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (d-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus. Vaccine 29(15), 2712–2719 (2011).
  • Ahmed R, Oldstone MB, Palese P. Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic. Nat. Immunol. 8(11), 1188–1193 (2007).
  • Feigin RD, Cherry J, Demmler GJ, Kaplan S. Textbook of Pediatric Infectious Diseases (5th Edition). WB Saunders, PA, USA (2004).
  • Madan RP, Tan M, Fernandez-Sesma A et al. A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings. Clin. Infect. Dis. 46(5), 712–718 (2008).
  • Forrest BD, Pride MW, Dunning AJ et al. Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children. Clin. Vaccine Immunol. 15(7), 1042–1053 (2008).
  • Díez-Domingo J, Garcés-Sanchez M, Baldó JM et al. Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-adjuvanted prepandemic candidate influenza vaccines in children aged 3 to 9 years: a phase ii, randomized, open, controlled study. Pediatr. Infect. Dis. J. 29(6), e35–e46 (2010).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.